Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.
ncRNA
CASC2a
Specific or universal ncRNAs
Specific ncRNAs
Class
Long non-coding RNA
Biomarker
Yes
Biomarker application
Prognosis/Treatment
Upstream regulatory factor
Not available
Downstream target
Not available
Differential expression in
recurrence vs. nonrecurrence
Not available
Cancer name
Urothelial Carcinoma of Bladder
Alias
Bladder Cancer
Cancer site
Bladder
Recurrence type
Early Recurrence
Overall survival rate of patients with
high ncRNA expression
Up
ncRNA differential expression in
cancer
patients vs. health people
Not available
Number of patients
112
Male patients
89
Female patients
23
Age range and number
Not available
Recurrence patients
Not available
Recurrence patients male:female
Not available
Recurrence patients age range
Not available
Recurrence mean age
Not available
Sites of recurrence
Not available
Patients without recurrence
Not available
Patients without recurrence male:female
Patients without recurrence age range
Not available
Patients without recurrence mean age
Not available
PMID
Description
Patients with a high expression of CASC2a had a higher 5-year recurrence-free survival rate than those with low expression of CASC2a.
Tissue resource
urothelial carcinoma of bladder tissues and paired adjacent normal tissues
Experiment
qRT-PCR
Institute
the Affiliated Hospital of Hangzhou Normal University
Country
China
Continent
Asia
Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.